Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Volume 5, Issue 2, April 2021, Pages 516-519
Case reportThe Impact of COVID-19 on Volume of Inpatient Hospitalization Through General Medicine and Medicine Subspecialty Services at US Medical Centers
Under a Creative Commons license
open access
Abbreviations and Acronyms
COVID-19
coronavirus disease 2019
Cited by (0)
Potential Competing Interests: Dr Amin reported serving as principal investigator or co-investigator of clinical trials sponsored by NIH/NIAID, NeuroRx Pharma, Pulmotect, Blade Therpeutics, Novartis, Takeda, Humanigen, Eli Lilly, PTC Therapeutics, Octapharma, Fulcrum Therapeutics, Alexion; and he has served as speaker and/or consultant for BMS, Pfizer, BI, Portola, Sunovion, Mylan, Salix, Alexion, AstraZeneca, Novartis, Nabriva, Paratek, Bayer, Tetraphase, Achogen LaJolla, Millenium, Ferring, PeraHealth, HeartRite, Aseptiscope, and Sprightly. Dr Nguyen reported serving as a speaker for Olympus and Endogastric Solutions.
The remaining authors report no potential competing interests.
© 2021 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.